SER

MKT CAP:$27M

Serina Therapeutics Inc

Market Cap

$27M

Healthcare·Biotechnology·🇺🇸 United States·AMEX

Healthcare·Biotechnology·🇺🇸·AMEX

Stock Price

$1.88-$0.20 (-9.53%)

Jun 5, 2026

52W High $6.1852W Low $1.28

Company Details

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is i...

CEO

—

IPO Date

Nov 29, 2018

Website

serinatherapeutics.com

Key Metrics TTM

Revenue

$130.0K

+154.9% YoY

Net Income

-$21M

EPS (Diluted)

Free Cash Flow

-$18M

Revenue / Share

$0.01

Gross Margin

43.1%

Operating Margin

-18803.1%

Net Margin

-16359.2%

FCF Margin

-14030.0%

P/S

208.8x

P/E

Earnings Reports

Q1 2026

May 14, 2026

FY 2025

Mar 25, 2026

$130.0K+132.1%

Q4 2025

Mar 25, 2026

$0+100.0%

Q3 2025

Nov 13, 2025

$0-100.0%

Q2 2025

Aug 11, 2025

$130.0K+154.9%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee